Pages that link to "Q46295878"

The following pages link to A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor (Q46295878):

Displaying 33 items.

• Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva (Q24623325) (← links)
• The biological function of type I receptors of bone morphogenetic protein in bone (Q26752839) (← links)
• Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma (Q28237518) (← links)
• From mysteries to medicines: drug development for fibrodysplasia ossificans progressive (Q33555767) (← links)
• Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants (Q34313807) (← links)
• Bone Morphogenetic Protein (BMP) signaling in development and human diseases (Q34512444) (← links)
• Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis (Q34644842) (← links)
• Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma (Q34810691) (← links)
• Neofunction of ACVR1 in fibrodysplasia ossificans progressiva (Q36394399) (← links)
• Sporadic Fibrodysplasia Ossificans Progressiva in an Egyptian Infant with c.617G > A Mutation in ACVR1 Gene: A Case Report and Review of Literature (Q36593023) (← links)
• Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling (Q38926047) (← links)
• Structural Basis of Intracellular TGF-β Signaling: Receptors and Smads (Q38934096) (← links)
• Mutant activin-like kinase 2 in fibrodysplasia ossificans progressiva are activated via T203 by BMP type II receptors (Q38944117) (← links)
• Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism (Q38963434) (← links)
• Disease-causing allele-specific silencing against the ALK2 mutants, R206H and G356D, in fibrodysplasia ossificans progressiva (Q39255284) (← links)
• Identification and functional analysis of Zranb2 as a novel Smad-binding protein that suppresses BMP signaling. (Q39454032) (← links)
• Pathogenic mutation of ALK2 inhibits induced pluripotent stem cell reprogramming and maintenance: mechanisms of reprogramming and strategy for drug identification (Q39558424) (← links)
• A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H (Q39580868) (← links)
• New Protocol to Optimize iPS Cells for Genome Analysis of Fibrodysplasia Ossificans Progressiva. (Q41215881) (← links)
• Suppression of BMP-Smad Signaling Axis-Induced Osteoblastic Differentiation by Small C-terminal Domain Phosphatase 1, a Smad Phosphatase (Q41785848) (← links)
• Peripheral blood mononuclear cell immunophenotyping in fibrodysplasia ossificans progressiva patients: Evidence for monocyte DNAM1 up-regulation. (Q41922754) (← links)
• Mutation Detection in Activin A Receptor, Type I (ACVR1) Gene in Fibrodysplasia Ossificans Progressiva in An Iranian Family (Q41975194) (← links)
• Exogenous activation of BMP-2 signaling overcomes TGFβ-mediated inhibition of osteogenesis in Marfan embryonic stem cells and Marfan patient-specific induced pluripotent stem cells. (Q45125619) (← links)
• Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope? (Q47580461) (← links)
• Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva (Q48009686) (← links)
• Bone Morphogenetic Proteins (Q51724862) (← links)
• The Horizon of a Therapy for Rare Genetic Diseases: A "Druggable" Future for Fibrodysplasia Ossificans Progressiva. (Q52340220) (← links)
• Fibrodysplasia ossificans progressiva: middle-age onset of heterotopic ossification from a unique missense mutation (c.974G>C, p.G325A) in ACVR1. (Q54546270) (← links)
• An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva (Q58569719) (← links)
• Recent Topics in Fibrodysplasia Ossificans Progressiva (Q58725014) (← links)
• Discovery of Heterotopic Bone-Inducing Activity in Hard Tissues and the TGF-β Superfamily (Q59808932) (← links)
• Insights into the biology of fibrodysplasia ossificans progressiva using patient-derived induced pluripotent stem cells (Q64058749) (← links)
• The role of Activin A in fibrodysplasia ossificans progressiva: a prominent mediator (Q92152712) (← links)